02848nam 2200637 a 450 991082405190332120231110224239.01-118-35444-31-118-50949-81-118-35443-51-118-35442-7(CKB)2670000000353323(EBL)1173429(OCoLC)808685068(SSID)ssj0000871623(PQKBManifestationID)11439475(PQKBTitleCode)TC0000871623(PQKBWorkID)10820594(PQKB)10113245(MiAaPQ)EBC1173429(DLC) 2012035252(Au-PeEL)EBL1173429(CaPaEBR)ebr10691507(CaONFJC)MIL484642(MiAaPQ)EBC7103576(Au-PeEL)EBL7103576(EXLCZ)99267000000035332320120828d2013 uy 0engurcn|||||||||txtccrHeterocyclic chemistry in drug discovery[electronic resource] /edited by Jie Jack LiHoboken, N.J. Wiley20131 online resource (722 p.)New York Academy of Sciences Description based upon print version of record.1-118-14890-8 Includes bibliographical references and index.2. Pyrroles -- 3. Indoles -- 4. Furans, benzofurans, thiophenes, and benzothiophenes -- 5. Pyrazoles, pyrazolones, and indazoles -- 6. Oxazoles, isoxazoles, and oxazolidinones -- 7. Thiazoles and benzothiazoles -- 8. Imidazoles and benzimidazoles -- 9. Triazoles and tetrazoles -- 10. Pyridines -- 11. Quinolines and isoquinolines -- 12. Pyrazines and quinoxalines -- 13. Pyrimidines -- 14. Quinazolines and quinazolones.Enables researchers to fully realize the potential to discover new pharmaceuticals among heterocyclic compounds Integrating heterocyclic chemistry and drug discovery, this innovative text enables readers to understand how and why these two fields go hand in hand in the effective practice of medicinal chemistry. Contributions from international leaders in the field review more than 100 years of findings, explaining their relevance to contemporary drug discovery practice. Moreover, these authors have provided plenty of practical guidance and tips based on their own academic and iNew York Academy of Sciences Drug developmentHeterocyclic compoundsDrug development.Heterocyclic compounds.615.1/9Li Jie Jack440094MiAaPQMiAaPQMiAaPQBOOK9910824051903321Heterocyclic chemistry in drug discovery4073913UNINA